Improving monitoring methods for advanced prostate cancer treatment
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
This study is looking to improve how we track metastatic castration-resistant prostate cancer by using a mix of blood tests and advanced imaging to get a clearer picture of the disease, helping doctors better understand how well treatments are working for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10892888 on NIH RePORTER |
What this research studies
This research focuses on enhancing the monitoring of metastatic castration-resistant prostate cancer by integrating fluid-based tumor monitoring with advanced imaging techniques. It aims to utilize circulating tumor cells (CTC) and automated imaging methods to provide a more comprehensive assessment of disease burden. By developing predictive models that combine these approaches, the research seeks to improve the accuracy of treatment response evaluations and overall survival predictions for patients. The study will test whether this combined method is more effective than current monitoring techniques.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with metastatic castration-resistant prostate cancer who are undergoing treatment.
Not a fit: Patients with early-stage prostate cancer or those not receiving treatment for metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate monitoring of treatment responses, ultimately improving outcomes for patients with advanced prostate cancer.
How similar studies have performed: Previous research has shown promise in using similar combined approaches for monitoring cancer treatment, indicating potential for success in this study.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Schwartz, Lawrence H — Sloan-Kettering Inst Can Research
- Study coordinator: Schwartz, Lawrence H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.